AAPL   315.48 (-0.39%)
MSFT   178.55 (-1.66%)
FB   225.33 (-2.96%)
GOOGL   1,411.05 (-0.73%)
AMZN   2,386.19 (-1.47%)
CGC   19.39 (-3.10%)
BABA   200.23 (-0.74%)
GE   7.30 (+7.35%)
TSLA   803.61 (-1.86%)
AMD   50.50 (-5.06%)
ACB   15.30 (-1.99%)
DIS   121.56 (+0.50%)
BAC   25.55 (+5.23%)
AAPL   315.48 (-0.39%)
MSFT   178.55 (-1.66%)
FB   225.33 (-2.96%)
GOOGL   1,411.05 (-0.73%)
AMZN   2,386.19 (-1.47%)
CGC   19.39 (-3.10%)
BABA   200.23 (-0.74%)
GE   7.30 (+7.35%)
TSLA   803.61 (-1.86%)
AMD   50.50 (-5.06%)
ACB   15.30 (-1.99%)
DIS   121.56 (+0.50%)
BAC   25.55 (+5.23%)
AAPL   315.48 (-0.39%)
MSFT   178.55 (-1.66%)
FB   225.33 (-2.96%)
GOOGL   1,411.05 (-0.73%)
AMZN   2,386.19 (-1.47%)
CGC   19.39 (-3.10%)
BABA   200.23 (-0.74%)
GE   7.30 (+7.35%)
TSLA   803.61 (-1.86%)
AMD   50.50 (-5.06%)
ACB   15.30 (-1.99%)
DIS   121.56 (+0.50%)
BAC   25.55 (+5.23%)
AAPL   315.48 (-0.39%)
MSFT   178.55 (-1.66%)
FB   225.33 (-2.96%)
GOOGL   1,411.05 (-0.73%)
AMZN   2,386.19 (-1.47%)
CGC   19.39 (-3.10%)
BABA   200.23 (-0.74%)
GE   7.30 (+7.35%)
TSLA   803.61 (-1.86%)
AMD   50.50 (-5.06%)
ACB   15.30 (-1.99%)
DIS   121.56 (+0.50%)
BAC   25.55 (+5.23%)
Log in

NVIDIA Co. Declares Quarterly Dividend of $0.16 (NASDAQ:NVDA)

Posted on Friday, May 22nd, 2020 by MarketBeat

NVIDIA Co. (NASDAQ:NVDA) declared a quarterly dividend on Friday, May 22nd, RTT News reports. Stockholders of record on Friday, June 5th will be given a dividend of 0.16 per share by the computer hardware maker on Friday, June 26th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.18%.

NVIDIA has raised its dividend by an average of 3.9% per year over the last three years and has increased its dividend every year for the last 7 years. NVIDIA has a dividend payout ratio of 11.1% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect NVIDIA to earn $7.65 per share next year, which means the company should continue to be able to cover its $0.64 annual dividend with an expected future payout ratio of 8.4%.

Shares of NVDA stock traded up $10.04 during trading hours on Friday, reaching $361.05. The company had a trading volume of 25,918,125 shares, compared to its average volume of 12,223,792. NVIDIA has a 12 month low of $132.60 and a 12 month high of $363.50. The company has a debt-to-equity ratio of 0.21, a current ratio of 7.67 and a quick ratio of 7.13. The business has a fifty day simple moving average of $290.96 and a 200-day simple moving average of $251.57. The company has a market cap of $222.16 billion, a price-to-earnings ratio of 79.67, a price-to-earnings-growth ratio of 3.76 and a beta of 1.33.

NVIDIA (NASDAQ:NVDA) last posted its earnings results on Thursday, May 21st. The computer hardware maker reported $1.80 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.36 by $0.44. NVIDIA had a return on equity of 26.08% and a net margin of 25.60%. The company had revenue of $3.08 billion for the quarter, compared to analyst estimates of $3 billion. During the same quarter last year, the company earned $0.88 earnings per share. The company's revenue for the quarter was up 38.7% on a year-over-year basis. On average, equities research analysts expect that NVIDIA will post 6.29 earnings per share for the current year.

In related news, Director Robert K. Burgess sold 20,000 shares of the business's stock in a transaction dated Monday, March 16th. The stock was sold at an average price of $222.33, for a total transaction of $4,446,600.00. Following the completion of the transaction, the director now directly owns 13,935 shares in the company, valued at $3,098,168.55. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Mark A. Stevens sold 10,000 shares of the business's stock in a transaction dated Wednesday, April 8th. The stock was sold at an average price of $266.02, for a total value of $2,660,200.00. Following the transaction, the director now owns 160,545 shares of the company's stock, valued at $42,708,180.90. The disclosure for this sale can be found here. Over the last quarter, insiders sold 105,669 shares of company stock valued at $27,025,985. 4.64% of the stock is owned by company insiders.

A number of research firms have recently weighed in on NVDA. Citigroup raised their target price on NVIDIA from $315.00 to $392.00 and gave the company a "buy" rating in a report on Friday. Credit Suisse Group began coverage on NVIDIA in a report on Thursday. They set an "outperform" rating and a $425.00 price target on the stock. Goldman Sachs Group reiterated a "buy" rating on shares of NVIDIA in a report on Tuesday, February 18th. UBS Group lifted their price target on NVIDIA from $330.00 to $400.00 and gave the stock a "buy" rating in a report on Friday. Finally, Rosenblatt Securities lifted their price target on NVIDIA from $340.00 to $400.00 and gave the stock a "buy" rating in a report on Friday. Four analysts have rated the stock with a sell rating, six have issued a hold rating, thirty-one have given a buy rating and one has issued a strong buy rating to the company's stock. NVIDIA has an average rating of "Buy" and an average price target of $340.41.

NVIDIA Company Profile

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the Graphics Processing Unit (GPU) and Tegra Processor segments. The GPU segment comprises of product brands which aims specialized markets including GeForce for gamers; Quadro for designers; Tesla and DGX for AI data scientists and big data researchers; and GRID for cloud-based visual computing users.

Read More: What does an outperform rating mean?

Dividend History for NVIDIA (NASDAQ:NVDA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]


15 Healthcare Stocks that Analysts Love

There are more than 200 healthcare companies traded on public markets. Given the sheer number of pharmaceutical companies, medical research firms, hospital systems and other healthcare stocks, it can be hard to identify which healthcare companies are going to outperform the market.

Fortunately, Wall Street's brightest minds have already done this for us. Every year, analyst issue approximately 3,000 distinct recommendations for healthcare companies. Analysts don't always get their "buy" ratings right, but it's worth taking a hard look when several analysts from different brokerages and research firm are giving "strong buy" and "buy" ratings to the same healthcare stock.

This slide show lists the 15 healthcare companies that have the highest average analyst recommendations from Wall Street's equities research analysts over the last 12 months.

View the "15 Healthcare Stocks that Analysts Love".

Free Email Newsletter

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.